Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures

W. U. Mirza; I. W. Rak; V. M. Thadani; J. J. Cereghino; W. R. Garnett; L. M. Brown; Y. Zhang; G. W. Belendiuk

doi:10.1212/WNL.51.6.1727

Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures

W. U. Mirza, I. W. Rak, V. M. Thadani, J. J. Cereghino, W. R. Garnett, L. M. Brown, Y. Zhang, G. W. Belendiuk

Neurology

Research output: Contribution to journal › Article

22 Scopus citations

Abstract

We evaluated the use of a new, controlled-release capsule form of carbamazepine, Carbatrol capsules, in an open-label, multicenter study of 124 patients with complex partial seizures. Ninety-one percent of the patients successfully completed the 6-month trial with good seizure control, with a significant improvement in quality of life. We conclude that switching patients with complex partial seizures from multiple daily-dose carbamazepine to twice-daily Carbatrol on a milligram-to-milligram basis is relatively safe.

Original language	English (US)
Pages (from-to)	1727-1729
Number of pages	3
Journal	Neurology
Volume	51
Issue number	6
DOIs	https://doi.org/10.1212/WNL.51.6.1727
State	Published - Dec 1998

Fingerprint

ASJC Scopus subject areas

Clinical Neurology

Cite this

Mirza, W. U., Rak, I. W., Thadani, V. M., Cereghino, J. J., Garnett, W. R., Brown, L. M., Zhang, Y., & Belendiuk, G. W. (1998). Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures. Neurology, 51(6), 1727-1729. https://doi.org/10.1212/WNL.51.6.1727

@article{7613e74de2304321b2ba338980b6cdc0,

title = "Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures",

abstract = "We evaluated the use of a new, controlled-release capsule form of carbamazepine, Carbatrol capsules, in an open-label, multicenter study of 124 patients with complex partial seizures. Ninety-one percent of the patients successfully completed the 6-month trial with good seizure control, with a significant improvement in quality of life. We conclude that switching patients with complex partial seizures from multiple daily-dose carbamazepine to twice-daily Carbatrol on a milligram-to-milligram basis is relatively safe.",

author = "Mirza, {W. U.} and Rak, {I. W.} and Thadani, {V. M.} and Cereghino, {J. J.} and Garnett, {W. R.} and Brown, {L. M.} and Y. Zhang and Belendiuk, {G. W.}",

year = "1998",

month = dec

doi = "10.1212/WNL.51.6.1727",

language = "English (US)",

volume = "51",

pages = "1727--1729",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures

AU - Mirza, W. U.

AU - Rak, I. W.

AU - Thadani, V. M.

AU - Cereghino, J. J.

AU - Garnett, W. R.

AU - Brown, L. M.

AU - Zhang, Y.

AU - Belendiuk, G. W.

PY - 1998/12

Y1 - 1998/12

N2 - We evaluated the use of a new, controlled-release capsule form of carbamazepine, Carbatrol capsules, in an open-label, multicenter study of 124 patients with complex partial seizures. Ninety-one percent of the patients successfully completed the 6-month trial with good seizure control, with a significant improvement in quality of life. We conclude that switching patients with complex partial seizures from multiple daily-dose carbamazepine to twice-daily Carbatrol on a milligram-to-milligram basis is relatively safe.

AB - We evaluated the use of a new, controlled-release capsule form of carbamazepine, Carbatrol capsules, in an open-label, multicenter study of 124 patients with complex partial seizures. Ninety-one percent of the patients successfully completed the 6-month trial with good seizure control, with a significant improvement in quality of life. We conclude that switching patients with complex partial seizures from multiple daily-dose carbamazepine to twice-daily Carbatrol on a milligram-to-milligram basis is relatively safe.

UR - http://www.scopus.com/inward/record.url?scp=0031700770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031700770&partnerID=8YFLogxK

U2 - 10.1212/WNL.51.6.1727

DO - 10.1212/WNL.51.6.1727

M3 - Article

C2 - 9855533

AN - SCOPUS:0031700770

VL - 51

SP - 1727

EP - 1729

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -

Access to Document

10.1212/WNL.51.6.1727